Genome-wide association study of cutaneous squamous cell carcinoma
皮肤鳞状细胞癌的全基因组关联研究
基本信息
- 批准号:8628805
- 负责人:
- 金额:$ 34.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-03-01 至 2017-02-28
- 项目状态:已结题
- 来源:
- 关键词:AccountingActinic keratosisAddressAffectAgeAmericanAmericasAnatomic SitesBasal cell carcinomaBaseline SurveysBiopsyCaliforniaCharacteristicsChronicClinicalClinical MarkersCutaneousCutaneous MelanomaDNADataDatabasesDevelopmentDiagnosisDiseaseElectronic Health RecordElectronicsEnrollmentEnvironmentEnvironmental HealthEvaluationFirst Degree RelativeFutureGenderGenesGeneticGenetic DeterminismGenetic Predisposition to DiseaseGenotypeGoalsHealthHistologicIncidenceInvestigationLesionMalignant NeoplasmsMeasuresModelingNot Hispanic or LatinoPathologyPhysiciansPigmentation physiologic functionPopulationPopulation HeterogeneityPredispositionPreventivePublishingQuality ControlRegistriesResearchResourcesRiskRisk FactorsSample SizeSamplingSingle Nucleotide PolymorphismSkin CancerSmokingSquamous cell carcinomaStratificationSubgroupSyndromeTestingTimeUltraviolet RaysUnited StatesVariantbaseburden of illnesscancer riskcohortcostgene environment interactiongenetic associationgenetic resourcegenome wide association studygenome-wideimprovedmeetingsmelanomamemberprogramspublic health relevancescreeningskin squamous cell carcinomatumor
项目摘要
DESCRIPTION (provided by applicant): Cutaneous squamous cell carcinoma (SCC) is the second most common cancer in America, with over 700,000 cases diagnosed annually, and its incidence is on the rise. Despite the large population affected and resultant burden of disease, little is known about genetic determinants of SCCs. There are no published genome-wide association studies (GWAS) examining single nucleotide polymorphism (SNP) variants associated with SCC risk. The lack of published findings may be due, in part, to the fact that cutaneous SCCs are not reportable malignancies, and are therefore difficult to reliably identify. The electronic pathology databases at Kaiser Permanente Northern California (KNPC) overcome that barrier, and have been used to capture all biopsy-proven cutaneous SCCs from 1997 onward in a validated SCC registry. This project utilizes existing genetic data on over 675,000 SNPs from a large, well-characterized cohort of the Research Program on Genes, Environment and Health (RPGEH). The RPGEH has also collected comprehensive data including information on demographic and environmental variables on its cohort members. Using the unique resources of the RPGEH combined with the SCC Registry, we aim to perform a GWAS to identify SNP sequence variants associated with SCC risk on 77,578 non-Hispanic white RPGEH members, 5,953 of whom go on to develop at least one post-enrollment SCC. We will also test for interactions with established SCC risk factors, including pigmentation, gender, smoking, and actinic keratosis (a clinical marker for chronic ultraviolet light exposure). Furthermore, we will determine whether our identified SNP associations are stronger in subjects with multiple primary SCCs. In addition, we will evaluate whether there is any variation in SNP effects by tumor characteristics. Finally, we will compare our SNPs with those previously identified for BCCs and melanomas from published GWAS to attempt to identify genetic loci associated with skin cancer risk. Ultimately, we seek to improve our understanding of cutaneous SCCs and to identify mechanisms accounting for increased inherited susceptibility.
描述(由申请人提供):皮肤鳞状细胞癌(SCC)是美国第二大常见癌症,每年诊断超过70万例,其发病率呈上升趋势。尽管受影响的人群众多,并由此带来疾病负担,但对SCCs的遗传决定因素知之甚少。目前还没有发表的全基因组关联研究(GWAS)检查与SCC风险相关的单核苷酸多态性(SNP)变异。缺乏发表的研究结果可能部分是由于皮肤SCCs不是可报告的恶性肿瘤,因此难以可靠地识别。Kaiser Permanente北加州(KNPC)的电子病理数据库克服了这一障碍,并已用于捕获自1997年以来所有经活检证实的皮肤SCC。该项目利用来自基因、环境和健康研究计划(RPGEH)的一个大型、特征良好的队列的超过675,000个snp的现有遗传数据。人口与环境研究所还收集了全面的数据,包括关于其同组成员的人口和环境变量的资料。利用RPGEH与SCC登记处的独特资源,我们的目标是对77,578名非西班牙裔白人RPGEH成员进行GWAS,以确定与SCC风险相关的SNP序列变异,其中5,953人在入组后继续发展至少一种SCC。我们还将测试与现有SCC危险因素的相互作用,包括色素沉着、性别、吸烟和光化性角化病(慢性紫外线照射的临床标志)。此外,我们将确定我们发现的SNP关联是否在多发原发性SCCs患者中更强。此外,我们将根据肿瘤特征评估SNP效应是否存在变化。最后,我们将把我们的snp与先前从已发表的GWAS中发现的bcc和黑素瘤的snp进行比较,试图确定与皮肤癌风险相关的遗传位点。最终,我们寻求提高我们对皮肤SCCs的理解,并确定遗传易感性增加的机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARYAM Mandana ASGARI其他文献
MARYAM Mandana ASGARI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARYAM Mandana ASGARI', 18)}}的其他基金
Patient oriented research and mentoring program in dermatologic diseases
以患者为中心的皮肤病研究和指导计划
- 批准号:
10685455 - 财政年份:2023
- 资助金额:
$ 34.7万 - 项目类别:
Patient oriented research and mentoring program in dermatologic diseases
以患者为中心的皮肤病研究和指导计划
- 批准号:
10835532 - 财政年份:2023
- 资助金额:
$ 34.7万 - 项目类别:
Identification of genetic loci and pathways underlying hidradenitis suppurativa risk
识别化脓性汗腺炎风险的遗传位点和途径
- 批准号:
9976890 - 财政年份:2020
- 资助金额:
$ 34.7万 - 项目类别:
Identification of genetic loci and pathways underlying hidradenitis suppurativa risk
识别化脓性汗腺炎风险的遗传位点和途径
- 批准号:
10256622 - 财政年份:2020
- 资助金额:
$ 34.7万 - 项目类别:
The Role of Genetic Risk Factors in Keratinocyte Carcinoma Susceptibility
遗传危险因素在角质形成细胞癌易感性中的作用
- 批准号:
10606627 - 财政年份:2020
- 资助金额:
$ 34.7万 - 项目类别:
The Role of Genetic Risk Factors in Keratinocyte Carcinoma Susceptibility
遗传危险因素在角质形成细胞癌易感性中的作用
- 批准号:
10356846 - 财政年份:2020
- 资助金额:
$ 34.7万 - 项目类别:
The Role of Genetic Risk Factors in Keratinocyte Carcinoma Susceptibility
遗传危险因素在角质形成细胞癌易感性中的作用
- 批准号:
10116335 - 财政年份:2020
- 资助金额:
$ 34.7万 - 项目类别:
PQ3 Cutaneous squamous cell carcinoma: Integrating germline and somatic alterations that underlie tumor progression
PQ3 皮肤鳞状细胞癌:肿瘤进展背后的种系和体细胞改变的整合
- 批准号:
10380108 - 财政年份:2019
- 资助金额:
$ 34.7万 - 项目类别:
PQ3 Cutaneous squamous cell carcinoma: Integrating germline and somatic alterations that underlie tumor progression
PQ3 皮肤鳞状细胞癌:肿瘤进展背后的种系和体细胞改变的整合
- 批准号:
10836131 - 财政年份:2019
- 资助金额:
$ 34.7万 - 项目类别:
PQ3 Cutaneous squamous cell carcinoma: Integrating germline and somatic alterations that underlie tumor progression
PQ3 皮肤鳞状细胞癌:肿瘤进展背后的种系和体细胞改变的整合
- 批准号:
10115644 - 财政年份:2019
- 资助金额:
$ 34.7万 - 项目类别:
相似海外基金
A Phase 2, randomized, double-blind, 4-arm, multicenter study to demonstrate the efficacy and safety of topical dosage formulations of a prescription drug product for actinic keratosis
一项 2 期、随机、双盲、4 组、多中心研究,旨在证明处方药局部剂量制剂治疗光化性角化病的有效性和安全性
- 批准号:
10820810 - 财政年份:2023
- 资助金额:
$ 34.7万 - 项目类别:
Investigational new drug enabling studies for the development of a topical fixed dose combination drug product to treat actinic keratosis and prevent cutaneous squamous cell carcinoma.
研究性新药使研究能够开发局部固定剂量组合药物产品,以治疗光化性角化病和预防皮肤鳞状细胞癌。
- 批准号:
10482509 - 财政年份:2022
- 资助金额:
$ 34.7万 - 项目类别:
Skin Cancer Risks and Risk Prediction in Patients with Actinic Keratosis
光化性角化病患者的皮肤癌风险和风险预测
- 批准号:
10448977 - 财政年份:2022
- 资助金额:
$ 34.7万 - 项目类别:
Skin Cancer Risks and Risk Prediction in Patients with Actinic Keratosis
光化性角化病患者的皮肤癌风险和风险预测
- 批准号:
10610895 - 财政年份:2022
- 资助金额:
$ 34.7万 - 项目类别:
Investigational new drug enabling studies for the development of a topical fixed dose combination drug product to treat actinic keratosis and prevent cutaneous squamous cell carcinoma.
研究性新药使研究能够开发局部固定剂量组合药物产品,以治疗光化性角化病和预防皮肤鳞状细胞癌。
- 批准号:
10701001 - 财政年份:2022
- 资助金额:
$ 34.7万 - 项目类别:
MTAK - Microwave Therapy for Actinic Keratosis
MTAK - 光化性角化病的微波疗法
- 批准号:
103352 - 财政年份:2017
- 资助金额:
$ 34.7万 - 项目类别:
Collaborative R&D
From actinic keratosis to invasive squamous cell carcinoma: Impact of AHR and p27KIP1 on malignant transformation
从光化性角化病到浸润性鳞状细胞癌:AHR 和 p27KIP1 对恶性转化的影响
- 批准号:
511942584 - 财政年份:
- 资助金额:
$ 34.7万 - 项目类别:
Research Units
PHARMACOLOGY OF VITAMIN A IN PATIENTS WITH ACTINIC KERATOSIS
维生素 A 在光化性角化病患者中的药理学
- 批准号:
4691509 - 财政年份:
- 资助金额:
$ 34.7万 - 项目类别:
PHARMACOLOGY OF VITAMIN A IN PATIENTS WITH ACTINIC KERATOSIS
维生素 A 在光化性角化病患者中的药理学
- 批准号:
3962586 - 财政年份:
- 资助金额:
$ 34.7万 - 项目类别:














{{item.name}}会员




